Concord, MA, United States of America

Kleem Chaudhary


 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Hayward, CA (US) (2010)
  • Concord, MA (US) (2011 - 2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kleem Chaudhary

Introduction

Kleem Chaudhary is a notable inventor based in Concord, MA, who has made significant contributions to the field of antiviral research. With a total of four patents to his name, he has focused on developing compounds that can combat viral infections, particularly those associated with hepatitis C.

Latest Patents

Among his latest patents are antiviral phosphinate compounds. This invention relates to anti-viral phosphinate compounds, compositions containing such compounds, and therapeutic methods that include the administration of these compounds. Additionally, he has developed a method for treating disorders associated with hepatitis C by administering a pharmaceutical composition that comprises a therapeutically effective amount of an anti-viral phosphinate compound.

Career Highlights

Kleem Chaudhary is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its innovative therapies. His work at Gilead has allowed him to focus on the development of groundbreaking antiviral treatments that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Chaudhary has collaborated with esteemed colleagues such as Choung U Kim and Xiaoning C Sheng. These collaborations have further enhanced the research and development of antiviral therapies.

Conclusion

Kleem Chaudhary's contributions to antiviral research and his innovative patents underscore his importance in the field. His work continues to pave the way for new therapeutic methods that can significantly impact public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…